Taeyoung W. Koo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Correction: Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3-UPF1 splicing and surveillance axis.
Journal: Cell & bioscience
Published: July 12, 2026
Expert-involved continuous renal replacement therapy device development: addressing user needs through human factors engineering.
Journal: Expert review of medical devices
Published: September 16, 2025
Gene editing in cancer therapy: overcoming drug resistance and enhancing precision medicine.
Journal: Cancer gene therapy
Published: March 27, 2025
CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 12, 2023
CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy.
Journal: Translational neurodegeneration
Published: November 20, 2023
Survivin enhances hippocampal neurogenesis and cognitive function in Alzheimer's disease mouse model.
Journal: CNS neuroscience & therapeutics
Published: June 19, 2023
Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.
Journal: Experimental & molecular medicine
Published: August 18, 2022
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations.
Journal: Molecular therapy. Nucleic acids
Published: April 20, 2022
Correction to: Recent advances in CRISPR technologies for genome editing.
Journal: Archives of pharmacal research
Published: July 26, 2021
Recent advances in CRISPR technologies for genome editing.
Journal: Archives of pharmacal research
Published: March 09, 2021
Last Updated: 09/26/2026